After hearing about yet another death possibly attributed to a dietary supplement (this time it was White Mulberry Leaf), here is a handy guide you can use to find out if your dietary supplements are safe!
A thread by a medical toxicologist๐งต:
@HemeOncPharm@AlisonGulbis Agree! Other thoughts: (1) at least 30-40% of admin/research time should be provided. (2) mentorship - formal mentorship for junior clinicians is critical. (But: Mentors should be recognized, compensated, and given protected time).
Our MSKCC Leukemia PharmD teamโs comprehensive review of targeted therapy management in CLL is out!
We discuss the many clinical considerations going forward as the treatment landscape continues to evolve.
@sarahstump1 @PharmAnimal919 @MSKCancerCenter
https://t.co/I7982F9rvV
How do you treat patients with R/R Ph- ALL in first salvage? Check out our latest multicenter collab comparing outcomes with chemo vs novel therapy ๐
https://t.co/xaOvFDWhH1
@justinhreid Frustrating when there are so many important questions that would be best addressed with a multi-center analysis, but it takes months of red tape w/ inconsistent information to even begin data collection. ๐ตโ๐ซ
The #votes are counted & here's the results for the 2022-2023 Board of Elections.
LeAnne Kennedy - President-Elect
Amy Hatfield Seung - Treasurer
Shannon Hough - Board Member at Large
#Congratulations to our newest HOPA leaders!
https://t.co/cLqSyJNxaT
Thanks to all #candidates!
Looking for a PGY2 in Oncology? Join the Leaders and Best at the University of Michigan!ใฝ๏ธ
Come visit us virtually at the FREE @ACCP Residency Showcase TOMORROW from 1-4 pm CST.
Many other chances to learn more & chat with us in the next few months! ๐ https://t.co/SkSaVNQK0Q
Big thanks to our collaborators for making this paper possible. One thing is for certain: we need better treatment options for this patient population. @PharmAnimal919 #mpnsm
Our multicenter paper on HMA+Venetoclax in MPN-AP/BP is available: https://t.co/ZYMR4UN86B @PharmAnimal919 @tayweis@KuykendallMd@EuniceWangMD#mpnsm
Some thoughts:
I emphatically commend @ASH_hematology for printing and putting up posters of ALL PRESENTERS at no extra cost. This is not only a sign of flexibility during a pandemic, but also inclusivity to presenters from LMICs & who may have other challenges. Kudos to #ASH21@MartinTallman
The future is bright for HOPA!
Join us for the Incoming Presidentโs Message and Recognition of Board Members: A Journey of Gratitude, presented by Larry W. Buie, Pharm D, BCOP, FASHP.
TODAY AT 12:30 PM CDT
#leadership#HOPAAC21#gratitude